TCS vs. JWEL, ACI, REAL, FL, ASO, BABY, GPS, GCT, KAR, and M
Should you be buying Tecsys stock or one of its competitors? The main competitors of Tecsys include Jamieson Wellness (JWEL), TriSummit Utilities Inc. (ACI.TO) (ACI), Real Matters (REAL), Frontier Lithium (FL), Avesoro Resources (ASO), Else Nutrition (BABY), BSM Technologies (GPS), GVIC Communications (GCT), Karmin Exploration (KAR), and Mosaic Capital (M). These companies are all part of the "retail" industry.
Tecsys vs. Its Competitors
Jamieson Wellness (TSE:JWEL) and Tecsys (TSE:TCS) are both small-cap retail companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.
Jamieson Wellness has a beta of 1.197939, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Tecsys has a beta of 0.918859, indicating that its stock price is 8% less volatile than the S&P 500.
Jamieson Wellness has a net margin of 5.57% compared to Tecsys' net margin of 1.49%. Jamieson Wellness' return on equity of 8.99% beat Tecsys' return on equity.
49.6% of Jamieson Wellness shares are held by institutional investors. Comparatively, 30.3% of Tecsys shares are held by institutional investors. 0.3% of Jamieson Wellness shares are held by company insiders. Comparatively, 17.1% of Tecsys shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Jamieson Wellness presently has a consensus price target of C$42.40, suggesting a potential upside of 23.36%. Tecsys has a consensus price target of C$48.50, suggesting a potential upside of 46.97%. Given Tecsys' higher possible upside, analysts plainly believe Tecsys is more favorable than Jamieson Wellness.
Jamieson Wellness pays an annual dividend of C$0.84 per share and has a dividend yield of 2.4%. Tecsys pays an annual dividend of C$0.34 per share and has a dividend yield of 1.0%. Jamieson Wellness pays out 63.2% of its earnings in the form of a dividend. Tecsys pays out 111.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Jamieson Wellness is clearly the better dividend stock, given its higher yield and lower payout ratio.
Jamieson Wellness has higher revenue and earnings than Tecsys. Jamieson Wellness is trading at a lower price-to-earnings ratio than Tecsys, indicating that it is currently the more affordable of the two stocks.
In the previous week, Jamieson Wellness and Jamieson Wellness both had 1 articles in the media. Jamieson Wellness' average media sentiment score of 1.43 beat Tecsys' score of 0.59 indicating that Jamieson Wellness is being referred to more favorably in the media.
Summary
Jamieson Wellness beats Tecsys on 12 of the 16 factors compared between the two stocks.
Get Tecsys News Delivered to You Automatically
Sign up to receive the latest news and ratings for TCS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (TSE:TCS) was last updated on 10/17/2025 by MarketBeat.com Staff
